Dizal Pharma
China - ShanghaiPharmaceutical
Focus: Dizal Pharma is a Shanghai-based innovative medicines company focused on oncology, gastroenterology, and hematology with a clinical-stage pipeline spanning multiple modalities.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Dizal Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Dizal Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
DZD9008
Non Small Cell Lung CancerClinical Trials (1)
NCT05559645Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
N/AHelp build intelligence for Dizal Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.